loader
Please Wait
Applying Filters...

Quotient Sciences Quotient Sciences

X
menu

    Market Place

    Market Place

    Post Enquiry

    Post Enquiry
    menu

    List of All Manufacturers & Suppliers for 2070863 Licensing, EU CTD Dossiers, Marketing Authorizations, Finished Dosage Formulations listed on PharmaCompass.com

    Client Virtual Booth
    Menu

    Allergan Aesthetics

    EVENTS

    • Webinars & Exhibitions

    PRESENTATION(s)

    VIDEO(s)

    DIGITAL CONTENT

    DEVELOPMENTS

    DOSSIERs // Finished Dosage Forms

    INSPECTIONS & REGISTRATIONS

    PharmaCompass

    PharmaCompass Sponsored Ads

    Send me more info on How To Grow My Business Digitally?

    Left Arrow
    Right Arrow
    Filters Filter
    Cross PopUp
    FILTER :

    filter

    01 ACITRETIN (1)

    filter

    01 ALLERGAN INC (1)

    filter

    01 CAPSULE (1)

    filter

    01 25MG (1)

    filter

    01 Canada (1)

    ListList of Suppliers
    refresh Reset Filter
    refresh Reset Filter
    product-page Supplier Virtual Booth
    price-trend Ask Us
    Contact Supplier
    • FDA
    • EDQM
    Virtual Booth Upload your Marketing & Sales content on your company Virtual Booth, click HERE
    Contact Supplier Contact Supplier
    Flag U.S.A
    Virtual Booth Virtual Booth
    Digital Content Digital Content

    Acitretin

    PDF Supplier PDF
    URL Supplier Web Content
    CAPSULE
    25MG
    SORIATANE
    Canada
    2070863
    30
    Prescription
    Abbvie CB

    CPhI Japan

    Not Confirmed

    envelop Contact Supplier

    Looking for CTD TGA MCC DOSSIER APPLICATION 2070863

    Looking for CTD TGA MCC DOSSIER APPLICATION 2070863 1

    19

    Allergan Aesthetics, based in U.S.A, is a pharmaceutical company that stands out with its certifications from FDA and EDQM.

    One of their notable products is ACITRETIN, with a corresponding application number 2070863 and regulatory information .

    proudly manufactured in the

    Allergan Aesthetics's SORIATANE CAPSULE, medication with 25MG of ACITRETIN.

    Post Enquiry
    POST ENQUIRY